As of 31 Dec 2025, 1 institutional investors reported holding 135 shares of ALIGOS THERAPEUTICS INC - COM NEW (ALGS).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 135 | $1,258 | +$1,258 | $9.32 | 1 |
| 2025 Q3 | 90 | $882 | +$882 | $9.80 | 1 |
| 2025 Q1 | 0 | $0 | -$3,187 | $9.32 | 0 |
| 2024 Q4 | 80 | $3,187 | +$3,187 | $39.84 | 1 |
| 2024 Q3 | 0 | $0 | -$16,470,631 | $9.32 | 0 |
| 2024 Q2 | 47,289,231 | $16,550,223 | -$1,529,193 | $0.35 | 46 |
| 2024 Q1 | 46,213,782 | $45,289,023 | +$1,762,088 | $0.98 | 48 |
| 2023 Q4 | 45,349,616 | $30,110,233 | +$10,980,521 | $0.66 | 38 |
| 2023 Q3 | 25,733,959 | $19,221,516 | -$455,661 | $0.75 | 35 |
| 2023 Q2 | 26,288,408 | $25,523,780 | -$906,296 | $0.97 | 41 |
| 2023 Q1 | 27,346,271 | $23,898,125 | +$713,529 | $0.87 | 44 |
| 2022 Q4 | 26,502,366 | $25,252,021 | -$1,390,908 | $0.95 | 37 |
| 2022 Q3 | 27,621,215 | $30,382,000 | -$2,576,693 | $1.10 | 46 |
| 2022 Q2 | 29,780,237 | $36,037,000 | -$6,047,811 | $1.21 | 53 |
| 2022 Q1 | 31,743,187 | $68,243,000 | -$40,137,482 | $2.15 | 73 |
| 2021 Q4 | 32,893,048 | $390,439,854 | +$18,473,548 | $11.87 | 68 |
| 2021 Q3 | 31,209,242 | $483,854,781 | +$61,739,257 | $15.51 | 67 |
| 2021 Q2 | 27,010,311 | $550,373,359 | -$555,434 | $20.39 | 55 |
| 2021 Q1 | 27,027,085 | $612,383,000 | -$9,657,853 | $22.74 | 50 |
| 2020 Q4 | 27,265,688 | $749,471,000 | +$725,234,000 | $27.65 | 50 |